Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Recombinant human growth hormone + rosiglitazone[2] Rosiglitazone (PHL-rosiglitazone),
Somatotropin		[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 265 💬
2Rosiglitazone[1] Rosiglitazone (PHL-rosiglitazone)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[5] 46, 75, 97, 222, 265 💬
3Rosiglitazone (Avandia)[1] Rosiglitazone (PHL-rosiglitazone)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 222 💬
4Rosiglitazone Extended Release Tablets[1] Rosiglitazone (PHL-rosiglitazone)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 46 💬
5Rosiglitazone maleate[1] Rosiglitazone (PHL-rosiglitazone)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[3] 46, 75, 265 💬
6Rosiglitazone XR[1] Rosiglitazone (PHL-rosiglitazone)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 46 💬